throbber
CASE 0:19-cv-01760-PJS-TNL Document 189-29 Filed 12/06/19 Page 1 of 4
`Document Number: PS1068
`Vascular Solutions, Inc.
`Rev. 01
`Product Requirements Document:
`Page 1 of 4
`GuideLiner Catheter System
`
`PRODUCT REQUIREMENTS:
`GuideLiner Catheter System
`
`Document Approvals:
`
`J. Kauphusman
`
`J. Kujawa
`
`8/24/05
`
`8/24/05
`
`Reviewer
`
`Documentation
`
`Distribution:
`
`1.
`
`INTRODUCTION
`
`1.1
`
`Scope
`
`This document defines the safety and perfounance requirements for the Vascular Solutions, Inc.
`GuideLiner (OTW) and rapid exchange (RX) guide catheter support system. These safety and
`perfoiniance features are the minimal requirements for the device to be acceptable for its intended
`clinical use. Applicable clinical use is for increase guide catheter back-up support.
`
`1.2
`
`References
`
`• Guidelines for the Submission of Research and Marketing Applications for Interventional
`Cardiology Devices. May 1994
`• BS EN ISO 10555 — 1:1997, Sterile Single-use Intravascular Catheters.
`• Part 1: General Requirements,
`• ISO 10993:2003 Biological Evaluation of Medical Devices
`• European Sterilization Standard BS EN 556: 1995 Sterilization of Medical Devices —
`Requirements for Teiminally Sterilized Devices to be Labeled Sterile
`• ISO 10993-07; 1995 (E) Ethylene Oxide Sterilization Residuals
`• ISO 594-1:1986 Conical Fittings with 6% Luer Taper
`• ISO 594-2:1998 Conical Fittings with 6% Luer Taper
`• ASTM D 4169-01; Transportation Testing (DC13 AL II)
`• ASTM F 2096-02; Bubble Leak Test
`• MDD 13.3: 21 CFR 801
`
`2.
`
`SYSTEM OVERVIEW
`
`2.1.
`
`General Description
`
`During many coronary interventions the back-up support provided by commonly used guide catheters
`are inadequate to deliver guidewires and PTCA treatment catheters through tortuous anatomy or severe
`stenosis. Advancing a PTCA catheter against resistance causes the guide catheter to back out of the
`coronary ostium rather than advancing the PTCA catheter. The GuideLiner will provide a simple means
`
`Confidential - Attorneys' Eyes Only
`
`VSIMDT00030178
`
`- - Confidential - -
`
`EXHIBIT 29
`
`Page 1
`
`Teleflex Ex. 2024
`Medtronic v. Teleflex
`IPR2020-00132
`
`Page 1
`
`Teleflex Ex. 2024
`Medtronic v. Teleflex
`IPR2020-00126
`
`PROTECTIVE ORDER MATERIAL
`
`

`

`CASE 0:19-cv-01760-PJS-TNL Document 189-29 Filed 12/06/19 Page 2 of 4
`Document Number: PS1068
`Vascular Solutions, Inc.
`Rev. 01
`Product Requirements Document:
`Page 2 of 4
`GuideLiner Catheter System
`
`by which the operator can increase the back-up support of a guide catheter by coaxially inserting a
`GuideLiner into the guide catheter.
`
`2.2.
`
`Product Philosophy
`
`Vascular Solutions strives to introduce products which are an improvement over current technology.
`VSI' s new products must be simple to use, meet clinicians' needs, and improve quality of life for the
`patient. These devices must also meet the financial needs of today's healthcare environment
`
`2.3.
`
`User Profiles
`
`2.3.1.
`
`Physician
`
`• Responsible for the health and comfort of patient
`• Require products to be reliable and pose minimal risk to the patient
`• Under cost containment pressure and will evaluate 'value' of product
`• Interventional Cardiologists and Radiologists are trained in this procedure
`
`2.3.2.
`
`Administration/Risk Management
`
`• Look at the full cost of treatment of a disease state including complications
`• Evaluate ways to reduce risk of complications
`
`2.4.
`
`Key Assumptions
`
`2.4.1. During interventional cases where the physician is attempting to reach into tortuous vessels, or
`where the arteries are more difficult to cross, additional back-up of the guide catheter may be
`achieved either through improved engagement of the coronary system, or by providing
`additional stiffness to the guide catheter.
`Treatment catheters have a useable length of —135cm
`Guide catheters have a maximum overall length of 109cm
`
`2.4.2.
`2.4.3.
`
`3.
`
`REQUIREMENTS/SPECIFICATIONS
`
`PRODUCT SPECIFICATIONS
`
`N
`
`TEST METHOD
`N
`,
`
`USER REQUIREMENTS
`3.1 Performance Requirements
`The catheter system must allow for
`advancement of the treatment catheter beyond
`(deeper) than using a guide catheter alone
`The catheter system must be capable of
`withstanding nounal insertion and removal
`forces through commonly used guide catheters
`and through the arterial system.
`The catheter system must slide inside the guide
`catheter and through the anticipated
`vasculature and be able to navigate the blood
`vessels without kinking.
`The catheter system must provide for an
`atraumatic entry into and travel through the
`blood vessel.
`
`Confidential - Attorneys' Eyes Only
`
`VSIMDT00030179
`
`- - Confidential - -
`
`EXHIBIT 29
`
`Page 2
`
`Teleflex Ex. 2024
`Medtronic v. Teleflex
`IPR2020-00132
`
`Page 2
`
`Teleflex Ex. 2024
`Medtronic v. Teleflex
`IPR2020-00126
`
`PROTECTIVE ORDER MATERIAL
`
`

`

`CASE 0:19-cv-01760-PJS-TNL Document 189-29 Filed 12/06/19 Page 3 of 4
`Document Number: PS1068
`Vascular Solutions, Inc.
`Rev. 01
`Product Requirements Document:
`Page 3 of 4
`GuideLiner Catheter System
`
`The most distal position of the catheter system
`must be visible using standard fluoroscopic
`methods.
`Catheter system must be capable of delivering
`standard PTCA treatment catheters.
`
`Catheter and dilator must be able to be flushed
`with liquid prior to introduction into the guide
`catheter.
`
`The catheter surfaces shall be free of
`extraneous matter.
`The catheter system must be sterile
`
`3.2 Dimensional requirements
`The catheter must be capable of being
`deployed over a .014" guidewire.
`
`The catheter must be able to be deployed
`through a standard coronary guide catheter
`used in percutaneous procedures in both
`diameter and length.
`
`The catheter must be able to be locked in
`position relative to the guide catheter
`
`The length of the catheter must not prevent or
`limit the treatment catheter or stent delivery
`system from being fully deployed.
`
`'0,Vhemical & Biologic Properties,W
`All bio-contact materials used must be
`compatible with the biological tissues, cells
`and fluids.
`EO residual levels of blood contact
`components must meet required medical
`device criteria.
`The device must not contain any Latex
`materials
`3.4 Infection & microbial contamination
`The catheter surfaces must be free of sharp
`edges.
`The device must be non-pyrogenic.
`
`All components entering the sterile field and
`intended for contact with human tissue must be
`sterile.
`
`A,r
`
`Confidential - Attorneys' Eyes Only
`
`VSIMDT00030180
`
`- - Confidential - -
`
`EXHIBIT 29
`
`Page 3
`
`Teleflex Ex. 2024
`Medtronic v. Teleflex
`IPR2020-00132
`
`Page 3
`
`Teleflex Ex. 2024
`Medtronic v. Teleflex
`IPR2020-00126
`
`PROTECTIVE ORDER MATERIAL
`
`

`

`CASE 0:19-cv-01760-PJS-TNL Document 189-29 Filed 12/06/19 Page 4 of 4
`Document Number: PS1068
`Vascular Solutions, Inc.
`Rev. 01
`Product Requirements Document:
`Page 4 of 4
`GuideLiner Catheter System
`
`The catheter should be packaged in such a
`manner to protect the catheter and
`components.
`Catheter must have a reasonable shelf life.
`
`Catheter and package configuration must be
`designed for typical laboratory environment
`storage conditions.
`3.6 Ergonomic Requirements
`The catheter system should employ techniques
`and components that are familiar to the
`physician.
`The RX version of the catheter system should
`be capable of being used by one physician.
`3.7 Interfaces with other devices k 1
`The catheter system connections must be able
`to interface with standard connectors.
`The catheter system must be able to pass a
`.014" guidewire.
`The 5 in 6 catheter must be able to interface
`with a .070" guide catheter.
`The 6 in 7 catheter must be able to interface
`with a 0.078" guide catheter
`The 7 in 8 catheter must be able to interface
`with a 0.088" guide catheter.
`
`4.
`
`REVISION HISTORY
`
`Rev.
`01
`
`Effective Date
`8/24/05
`
`DCO #
`4029
`
`Reason
`Pre-release
`
`Confidential - Attorneys' Eyes Only
`
`VSIMDT00030181
`
`- - Confidential - -
`
`EXHIBIT 29
`
`Page 4
`
`Teleflex Ex. 2024
`Medtronic v. Teleflex
`IPR2020-00132
`
`Page 4
`
`Teleflex Ex. 2024
`Medtronic v. Teleflex
`IPR2020-00126
`
`PROTECTIVE ORDER MATERIAL
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket